BRIEF-CSL Behring says Australian Therapeutic Goods Administration approved Afstyla
April 19, 2017 at 14:36 PM EDT
* Csl behring -australian therapeutic goods administration approved afstyla a recombinant single chain coagulation factor viii in patients with haemophilia a Source text for Eikon: Further company coverage:
